-
Press Release
Statement on FDA Draft Guidance for Alzheimer’s Drug Development
-
Document, Feature Article
Translating Innovation to Impact
This white paper presents the findings and recommendations from a review of the state of the art non-pharmacological treatments and care practices for people with Alzheimer's or other dementias and their family caregivers. It is intended to support deliberations by the Advisory Council on Alzheimer's Research, Care and Services, the U.S. Department of Health & Human Services (HHS) and other government and private organizations about hot to make effective non-pharmacological treatments and care practices available to people who will benefit from then. Its development resulted from a public-private partnership between AoA and the Alliance for Aging Research, with funding from the Metlife Foundation.
-
Press Release
Teleconference explains ways to reduce Medicare costs
Kenneth E. Thorpe, PhD, professor of Health Policy and Management at Emory’s Rollins School of Public Health along with colleague Daniel Perry, president and CEO of the Alliance for Aging Research, suggest adopting specific initiatives such as transitional and team-based care, comprehensive medication therapy management, and health coaching to slow the growth in spending and improve quality of care. The team will host a teleconference on Thursday, December 13 from 10:30 a.m. – 11 a.m. to discuss these recommendations.
-
Document
Assessing Stroke and Bleeding Risk in Atrial Fibrillation
This expert consensus statement makes important recommendations on the use of stroke and bleeding risk tools, the decision to anticoagulate, the incorporation of patient preferences, and more.
-
Report
The Silver Book: Vision Loss Volume II
More than 38 million Americans age 40 and older are blind, visually impaired, or have an age-related eye disease, and adult vision loss costs our economy more than $51 billion a year. With major advances in vision research bringing new prevention and treatments, it is critical that support for research and incentives for innovation remain a priority.
In order to highlight this important data and encourage conversations and policies that look to investments in innovation rather than short-term cost-cutting and health care rationing, the Alliance for Aging Research has teamed up with the Alliance for Eye and Vision Research (AEVR) during their Decade of Vision, to release Volume II of The Silver Book®:Vision Loss. Volume II brings updated data on age-related macular degeneration (AMD), diabetic retinopathy, and glaucoma—which along with cataract, are the eye diseases that disproportionately impact older Americans. This new volume also highlights the exciting changes and discoveries in vision research and treatment from the past 5 years.
